{"id":5651,"date":"2025-07-31T11:10:40","date_gmt":"2025-07-31T15:10:40","guid":{"rendered":"https:\/\/www.bvimedical.com\/us\/?p=5651"},"modified":"2025-08-01T10:41:15","modified_gmt":"2025-08-01T14:41:15","slug":"bvi-debuts-leos-fda-cleared-laser-endoscopy-system-offering-a-new-standard-in-minimally-invasive-glaucoma-surgery","status":"publish","type":"post","link":"https:\/\/www.bvimedical.com\/us\/bvi-debuts-leos-fda-cleared-laser-endoscopy-system-offering-a-new-standard-in-minimally-invasive-glaucoma-surgery\/","title":{"rendered":"BVI Debuts Leos\u2122 &#8211; FDA-Cleared Laser Endoscopy System Offering a New Standard in Minimally Invasive Glaucoma Surgery"},"content":{"rendered":"\n<ul class=\"wp-block-list\">\n<li>BVI\u2019s Leos\u2122 system has been used clinically for the first time, marking a major milestone following its <a href=\"https:\/\/www.bvimedical.com\/bvi-medical-announces-approval-of-breakthrough-technology-fda-510k-clearance-of-its-laser-endoscopy-ophthalmic-system-leos\/\">FDA 510(k) clearance in April 2025<\/a>.<\/li>\n\n\n\n<li>Leos\u2122 is the first and only FDA-cleared laser system with advanced digital endoscopic visualization for ab interno intraocular pressure reduction.<\/li>\n<\/ul>\n\n\n\n<p><strong>WALTHAM, Mass., July 31, 2025<\/strong> \u2013 BVI, a leading global ophthalmic device company dedicated to sitting at the forefront of advancements in eye surgery, today announced the first clinical use of its FDA-cleared Leos\u2122 Laser Endoscopy Ophthalmic System. The milestone procedure was performed by Dr. Nathan Radcliffe, a glaucoma specialist at the Ambulatory Surgery Center of Greater New York, Bronx, NY.<\/p>\n\n\n\n<p>Leos\u2122, which received U.S. Food and Drug Administration (FDA) <a href=\"https:\/\/www.bvimedical.com\/bvi-medical-announces-approval-of-breakthrough-technology-fda-510k-clearance-of-its-laser-endoscopy-ophthalmic-system-leos\/\">510(k) clearance in April 2025<\/a>, is the first and only digital endoscopy and laser system designed to reduce intraocular pressure through an intuitive, minimally invasive ab interno approach\u2014while providing exceptional visualization of the eye\u2019s internal anatomy. The system represents a new evolution in endoscopic cyclophotocoagulation (ECP), integrating seamlessly into modern surgical workflows.<\/p>\n\n\n\n<p>\u201cThis first case highlights the potential of this technology to transform glaucoma management,\u201d said Dr. Radcliffe. \u201cLeos brings a new level of precision and efficiency to laser ECP, with enhanced visualization that improves both control and confidence in surgery.\u201d<\/p>\n\n\n\n<p>Designed to meet the evolving needs of surgeons treating a broad range of glaucoma patients\u2014including those in earlier stages of disease\u2014Leos is supported by emerging ECP clinical data and powered by advanced endoscopic visualization capabilities. The system enables a targeted, personalized approach to provide treatment for one of the world\u2019s leading causes of irreversible blindness.<\/p>\n\n\n\n<p>\u201cSeeing Leos used in a real-world surgical setting marks an important milestone for BVI and a testament to the progress we\u2019re making across our innovation pipeline,\u201d said Shervin Korangy, President and CEO of BVI. \u201cIt\u2019s incredibly rewarding to see our technologies have such a beneficial impact for both the surgeons and the patients they serve.\u201d<\/p>\n\n\n\n<p>BVI plans to commercially launch Leos in late 2025.<\/p>\n\n\n\n<p><strong>About BVI<\/strong><\/p>\n\n\n\n<p>BVI\u00ae is a diversified global ophthalmic device company with a mission to deliver high-quality solutions and innovation for advancing eye surgery and improving patients\u2019 vision. With nine decades of developing leading products and solutions, BVI partners with ophthalmic surgeons to improve the vision of millions of patients across the globe. Our organization supports surgical teams in more than 90 countries worldwide, either directly or through our network of trusted distributors.<\/p>\n\n\n\n<p>To learn more about BVI and its mission to advance the future of vision, visit <a href=\"https:\/\/www.bvimedical.com\">https:\/\/www.bvimedical.com<\/a><\/p>\n\n\n\n<p>***<\/p>\n\n\n\n<p><strong>Press Contact<\/strong><\/p>\n\n\n\n<p>David Chavez<\/p>\n\n\n\n<p>Global Communications Lead<\/p>\n\n\n\n<p>dchavez@bvimedical.com<\/p>\n\n\n\n<p>+1 (857) 869 8706<\/p>\n","protected":false},"excerpt":{"rendered":"<p>WALTHAM, Mass., July 31, 2025 \u2013 BVI, a leading global ophthalmic device company dedicated to sitting at the forefront of advancements in eye surgery, today announced the first clinical use of its FDA-cleared Leos\u2122 Laser Endoscopy Ophthalmic System. The milestone procedure was performed by Dr. Nathan Radcliffe, a glaucoma specialist at the Ambulatory Surgery Center [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"1,11,2870,2873,2876,2879","_relevanssi_noindex_reason":"","footnotes":""},"categories":[17],"tags":[],"class_list":["post-5651","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.bvimedical.com\/us\/wp-json\/wp\/v2\/posts\/5651","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bvimedical.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bvimedical.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bvimedical.com\/us\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bvimedical.com\/us\/wp-json\/wp\/v2\/comments?post=5651"}],"version-history":[{"count":0,"href":"https:\/\/www.bvimedical.com\/us\/wp-json\/wp\/v2\/posts\/5651\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.bvimedical.com\/us\/wp-json\/wp\/v2\/media?parent=5651"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bvimedical.com\/us\/wp-json\/wp\/v2\/categories?post=5651"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bvimedical.com\/us\/wp-json\/wp\/v2\/tags?post=5651"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}